Inebilizumab
CAS: 1299440-37-1
Ref. TM-T76713
| 1mg | 153.00 € | ||
| 5mg | 373.00 € | ||
| 10mg | 618.00 € | ||
| 25mg | 926.00 € | ||
| 50mg | 1,276.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Product Information
Name:
Inebilizumab
Synonyms:
- VIB-0551
- MT-0551
- MEDI 551
- 16C4-aFuc
- Uplizna
- Inebilizumab-cdon
- Immunoglobulin G1, anti-(human CD19 (antigen)) (human monoclonal MEDI-551 heavy chain), disulfide with human monoclonal MEDI-551 κ-chain, dimer
Description:
Inebilizumab: humanized anti-CD19 antibody, enhances cytotoxicity against B cells, treats autoimmune diseases like MS.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
146.60 kDa
Purity:
SDS-PAGE:99.3%;SEC-HPLC:96.2%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T76713 Inebilizumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
